Clinical Trial: PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07444645) titled 'PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System' on Feb. 26.

Brief Summary: This single-arm prospective study will compare CT-based tumor-to-normal ratio (TNR) measurements obtained using TriNav versus endhole microcatheters.

Study Start Date: Aug. 01, 2026

Study Type: INTERVENTIONAL

Condition: Tumor Liver

Intervention: DEVICE: Y90 Microsphere Therapy

Given by injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: M.D. Anderson Cancer Center

Published by HT Digital Content Services with pe...